D
Dizal Jiangsu Pharmaceutical Co Ltd
SSE:688192
Dizal Jiangsu Pharmaceutical Co Ltd
SSE:688192
Price:
57.91
CNY
1.31%
Market Closed
Market Cap:
¥26.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
D
|
Dizal Jiangsu Pharmaceutical Co Ltd
SSE:688192
|
CN |
|
Whirlpool China Co Ltd
SSE:600983
|
CN |
|
T
|
Titan America SA
NYSE:TTAM
|
BE |
|
W R Berkley Corp
NYSE:WRB
|
US |
|
Nexoptic Technology Corp
XTSX:NXO
|
CA |
|
B
|
Beijing Succeeder Technology Inc
SSE:688338
|
CN |
|
B
|
Bloom Energy Corp
SWB:1ZB
|
US |
|
Z
|
Zephyrus Wing Energies Ltd
TASE:ZPRS
|
IL |
|
Biomerieux SA
OTC:BMXMF
|
FR |
Cash Flow Statement
Cash Flow Statement
Dizal Jiangsu Pharmaceutical Co Ltd
Dizal Jiangsu Pharmaceutical Co Ltd
Currency: CNY
| Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||
| Stock-Based Compensation |
0
|
0
|
0
|
28
|
0
|
0
|
0
|
197
|
0
|
0
|
0
|
133
|
0
|
0
|
0
|
|
| Cash Taxes Paid |
24
|
63
|
74
|
69
|
74
|
27
|
16
|
5
|
(2)
|
(7)
|
(8)
|
(21)
|
(21)
|
(21)
|
(28)
|
|
| Change in Working Capital |
(254)
|
(200)
|
(224)
|
(236)
|
(268)
|
(309)
|
(343)
|
(406)
|
(445)
|
(517)
|
(614)
|
(626)
|
(663)
|
(713)
|
(737)
|
|
| Cash from Operating Activities |
(665)
N/A
|
(532)
+20%
|
(575)
-8%
|
(603)
-5%
|
(634)
-5%
|
(763)
-20%
|
(851)
-11%
|
(968)
-14%
|
(891)
+8%
|
(829)
+7%
|
(762)
+8%
|
(651)
+15%
|
(656)
-1%
|
(614)
+6%
|
(611)
+0%
|
|
| Investing Cash Flow | ||||||||||||||||
| Capital Expenditures |
(13)
|
(68)
|
(73)
|
(74)
|
(81)
|
(37)
|
(34)
|
(32)
|
(38)
|
(40)
|
(100)
|
(138)
|
(197)
|
(218)
|
(193)
|
|
| Other Items |
(1 552)
|
(1 543)
|
(1 437)
|
458
|
579
|
650
|
655
|
643
|
412
|
240
|
181
|
100
|
90
|
(261)
|
(210)
|
|
| Cash from Investing Activities |
(1 564)
N/A
|
(1 610)
-3%
|
(1 510)
+6%
|
385
N/A
|
498
+30%
|
613
+23%
|
620
+1%
|
611
-1%
|
374
-39%
|
200
-46%
|
82
-59%
|
(38)
N/A
|
(106)
-179%
|
(479)
-351%
|
(403)
+16%
|
|
| Financing Cash Flow | ||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
100
|
0
|
0
|
0
|
1 776
|
1 776
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
80
|
200
|
338
|
521
|
547
|
640
|
760
|
856
|
504
|
175
|
|
| Cash Paid for Dividends |
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(3)
|
(7)
|
(11)
|
(15)
|
(21)
|
(26)
|
(32)
|
(34)
|
|
| Other |
1 963
|
1 964
|
1 964
|
(33)
|
(24)
|
(19)
|
(25)
|
(27)
|
11
|
10
|
114
|
128
|
93
|
89
|
(17)
|
|
| Cash from Financing Activities |
1 963
N/A
|
1 964
+0%
|
1 964
0%
|
(33)
N/A
|
(24)
+28%
|
60
N/A
|
174
+189%
|
308
+77%
|
525
+70%
|
646
+23%
|
739
+14%
|
867
+17%
|
922
+6%
|
2 238
+143%
|
1 901
-15%
|
|
| Change in Cash | ||||||||||||||||
| Effect of Foreign Exchange Rates |
(7)
|
4
|
8
|
10
|
9
|
1
|
(5)
|
1
|
2
|
3
|
3
|
(2)
|
(2)
|
(3)
|
(2)
|
|
| Net Change in Cash |
(273)
N/A
|
(174)
+36%
|
(113)
+35%
|
(243)
-114%
|
(150)
+38%
|
(90)
+40%
|
(62)
+31%
|
(47)
+23%
|
10
N/A
|
21
+114%
|
61
+187%
|
176
+186%
|
157
-11%
|
1 142
+626%
|
884
-23%
|
|
| Free Cash Flow | ||||||||||||||||
| Free Cash Flow |
(678)
N/A
|
(600)
+12%
|
(648)
-8%
|
(677)
-5%
|
(714)
-6%
|
(801)
-12%
|
(885)
-11%
|
(1 000)
-13%
|
(929)
+7%
|
(869)
+6%
|
(862)
+1%
|
(788)
+9%
|
(853)
-8%
|
(832)
+2%
|
(805)
+3%
|
|
Switch to:
Switch to:
See Also
Discover More
